Home Page
01:32:54 EDT Sat 23 Aug 2014
Enter Symbol
or Name
USA
CA



VANGUARD HEALTH SYSTEMS INC
Symbol U : VHS
Recent Sedar Documents

Vanguard Health Systems Reports Second Quarter Fiscal 2013 Results

2013-01-30 18:19 ET - News Release


Company Website: http://vanguardhealth.com
NASHVILLE, Tenn. -- (Business Wire)

Vanguard Health Systems, Inc. (NYSE: VHS) today announced financial and operating results for its second fiscal quarter of 2013.

Second Quarter Fiscal 2013 Key Metrics (all percentage changes compare Q2 FY2013 to Q2 FY2012):

Consolidated and Same Store:

  • Net income attributable to Vanguard Health Systems, Inc. stockholders was $12.2 million, or $0.14 per diluted share, compared to net income of $15.7 million, or $0.20 per diluted share, during the prior year period
  • Adjusted EBITDA was $137.8 million
  • Patient revenue per adjusted discharge increased 1.5 percent
  • Discharges decreased 1.4 percent
  • Adjusted discharges increased 1.4 percent

Year to Date Fiscal 2013 Key Metrics (all percentage changes compare six months FY2013 to six months FY2012):

Consolidated:

  • Net income attributable to Vanguard Health Systems, Inc. stockholders was $26.1 million, or $0.31 per diluted share, compared to a net loss of $6.0 million, or $(0.08) per diluted share, during the prior year period
  • Adjusted EBITDA increased 4.9 percent to $271.0 million

Same Store:

  • Patient revenue per adjusted discharge increased 2.3 percent
  • Discharges decreased 1.8 percent
  • Adjusted discharges decreased 0.2 percent

A reconciliation of Adjusted EBITDA, a non-GAAP financial measure, to net income (loss) attributable to Vanguard Health Systems, Inc. stockholders for the quarters and six-month periods ending December 31, 2011 and 2012 is included in this release.

Second Quarter Analysis

Consolidated total revenues increased $37.7 million during the second quarter of fiscal 2013 compared to the prior year period. Net patient service revenues increased $33.2 million as a result of a 1.4 percent increase in adjusted discharges and a 1.5 percent increase in patient revenue per adjusted discharge. Emergency room visits increased 6.0 percent and observation cases increased 8.0 percent. Health plan premium revenues increased slightly during the second quarter of fiscal 2013 compared to the prior year period. Uncompensated care as a percentage of net patient revenues (prior to uncompensated care deductions) was 21.3 percent during the second quarter of fiscal 2013 compared to 20.0 percent during the prior year period primarily due to an increase in uninsured discharges as a percentage of total discharges.

Fiscal Year to Date Analysis

Consolidated total revenues increased $72.1 million during the six months ended December 31, 2012 compared to the prior year period, primarily due to the acquisition of Valley Baptist Health System in September 2011. Same store net patient service revenues increased 1.6 percent during the six months ended December 31, 2012 resulting from a 2.3 percent increase in patient revenue per adjusted discharge combined with a 0.2 percent decrease in adjusted discharges. Same store emergency room visits increased 3.8 percent and same store observation cases increased 9.1 percent during the six months ended December 31, 2012 compared to the prior year period. Health plan premium revenues, on a same store basis, decreased 10.4 percent during the six months ended December 31, 2012 compared to the prior year period. Phoenix Health Plan's revenues were negatively impacted by a combination of program changes adopted by Arizona Health Care Cost Containment System (“AHCCCS”) beginning April 1, 2011 and continuing during our fiscal year 2012, including capitation payment rate decreases, program eligibility restrictions and health plan profitability limitations for certain member groups.

Same store uncompensated care as a percentage of net patient revenues (prior to uncompensated care deductions) was 20.2 percent during the six months ended December 31, 2012 compared to 18.0 percent during the prior year period primarily due to an increase in uninsured discharges as a percentage of total discharges.

Balance Sheet and Cash Flows

As of December 31, 2012, we had cash of $357.8 million and total debt of $2,703.2 million.

Cash flows from operating activities improved by $81.1 million during the six months ended December 31, 2012 compared to the prior year period. Changes in net operating assets and liabilities negatively impacted operating cash flows by $92.9 million during the six months ended December 31, 2012 compared to a negative impact of $172.2 million during the prior year period. We made $98.2 million of interest and income tax payments during the six months ended December 31, 2012, which was $16.6 million higher than these payments during the prior year period.

Capital expenditures increased 36.4 percent to $187.2 million during the six months ended December 31, 2012 compared to the prior year period due to increased spending related to the Detroit Medical Center specified capital project commitments and the start of construction of a new hospital in New Braunfels, Texas.

Outlook for Fiscal Year 2013

We are confirming our previously issued fiscal year 2013 outlook for ranges of projected Adjusted EBITDA, projected net income attributable to Vanguard Health Systems, Inc. stockholders, projected diluted earnings per share and projected capital expenditures.

Earnings Conference Call

We will host a conference call at 11:00 a.m. EST on January 31, 2013. All interested parties are invited to access a live webcast of the conference call on the Investor Relations Section of our website at http://vanguardhealth.com.If you are unable to participate during the live webcast, the webcast will be available on a replay basis for 90 days.

We own and operate 28 acute care and specialty hospitals and complementary facilities and services in metropolitan Chicago, Illinois; metropolitan Detroit, Michigan; metropolitan Phoenix, Arizona; San Antonio, Texas; Harlingen and Brownsville, Texas; and Worcester and metropolitan Boston, Massachusetts. Our strategy is to develop locally branded, comprehensive health care delivery networks in urban markets.

Cautionary Statement about Forward-Looking Information

This press release contains “forward-looking statements” within the meaning of the federal securities laws that are intended to be covered by safe harbors created thereby. Forward-looking statements are those statements that are based upon management's plans, objectives, goals, strategies, future events, future revenue or performance, capital expenditures, financing needs, plans or intentions relating to acquisitions, business trends and other information that is not historical information. These statements are based upon estimates and assumptions made by our management that, although believed to be reasonable, are subject to numerous factors, risks and uncertainties that could cause actual outcomes and results to be materially different from those projected. When used in this press release, the words “estimates,” “expects,” “anticipates,” “projects,” “plans,” “intends,” “believes,” “forecasts,” “continues” or future or conditional verbs, such as “will,” “should,” “could” or “may,” and variations of such words or similar expressions are intended to identify forward-looking statements. These factors, risks and uncertainties include, among others, the following: our high degree of leverage and interest rate risk; our ability to incur substantially more debt; operating and financial restrictions in our debt agreements; our ability to generate cash necessary to service our debt; weakened economic conditions and volatile capital markets; potential adverse impact of pre-payment and post-payment claims reviews by governmental agencies; our ability to grow our business and successfully implement our business strategies, including growing our ambulatory care services platform; our ability to successfully integrate hospitals or ambulatory care facilities acquired in the future or to recognize expected synergies from such acquisitions; potential acquisitions could be costly, unsuccessful or subject us to unexpected liabilities; conflicts of interest that may arise as a result of our control by a small number of stockholders; the highly competitive nature of the health care industry; the geographic concentration of our operations; governmental regulation of the health care industry, including Medicare and Medicaid reimbursement levels in general and with respect to the impact of the Budget Control Act of 2011 and other future deficit reduction plans; a reduction or elimination of supplemental Medicare and Medicaid payments on which we depend, including disproportionate share payments, indirect medical education/graduate medical education payments, upper payment limit programs and other similar payments; pressures to contain costs by managed care organizations and other insurers and our ability to negotiate acceptable terms with these third party payers; our ability to attract and retain qualified management and health care professionals, including physicians and nurses; the currently unknown effect on us of the major federal health care reforms enacted by Congress in March 2010, including the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act of 2010, or other potential additional federal or state health care reforms, including that states may opt out of the Medicaid expansion; potential adverse impact of known and unknown governmental investigations and audits; increased compliance costs from further government regulation of the health care industry and our failure to comply, or allegations of our failure to comply, with applicable laws and regulations; our failure to adequately enhance our facilities with technologically advanced equipment; the availability of capital to fund our corporate growth strategy and improvements to our existing facilities; potential lawsuits or other claims asserted against us; our ability to maintain or increase patient membership in and to control the costs of our managed health care plans; failure of AHCCCS to renew its contract with, or award future contracts with similar terms and scope to, Phoenix Health Plan; Phoenix Health Plan's ability to comply with the terms of its contract with AHCCCS; our inability to manage health plan claims expense within our health plans; reductions in the enrollment of our health plans; changes in general economic conditions nationally and regionally in our markets; our exposure to the increased amounts of and collection risks associated with uninsured accounts and the co-pay and deductible portions of insured accounts; dependence on our senior management team and local management personnel; volatility of professional and general liability insurance for us and the physicians who practice at our hospitals and increases in the quantity and severity of professional liability claims; our ability to achieve operating and financial targets and to maintain and increase patient volumes and control the costs of providing services, including salaries and benefits, supplies and other operating expenses; technological and pharmaceutical improvements that increase the cost of providing, or reduce the demand for, health care services and shift demand for inpatient services to outpatient settings; a failure of our information systems; delays in receiving payments for services provided, especially from governmental payers; changes in revenue mix, including changes in Medicaid eligibility criteria and potential declines in the population covered under managed care agreements; costs and compliance risks associated with Section 404 of the Sarbanes-Oxley Act of 2002; material non-cash charges to earnings from impairment of goodwill associated with declines in the fair market value of our reporting units; cash payments that may be necessary to fund an underfunded defined benefit pension plan of the DMC; volatility of materials and labor costs for, or state efforts to regulate, potential construction projects that may be necessary for future growth; our reliance on payments from our subsidiaries, which may be restricted by our credit agreement and the indentures governing our senior notes; changes in accounting practices; our ability to demonstrate meaningful use of certified electronic health record technology and to receive the related Medicare or Medicaid incentive payments; and other risk factors described in our Annual Report on Form 10-K and other filings with the Securities and Exchange Commission.

Our forward-looking statements speak only as of the date made. Except as required by law, we undertake no obligation to publicly update or revise any forward-looking statements contained herein, whether as a result of new information, future events or otherwise. You are cautioned not to rely on such forward-looking statements when evaluating the information contained in this press release. In light of significant uncertainties inherent in the forward-looking statements included in this press release, you should not regard the inclusion of such information as a representation by us that the objectives and plans anticipated by the forward-looking statements will occur or be achieved or, if any of them do, what impact they will have on our financial condition, results of operations or cash flows.

We use our company website to provide important information to investors about the company, including the posting of important announcements regarding financial performance and corporate developments.

 
 
 
 
 
VANGUARD HEALTH SYSTEMS, INC.
Condensed Consolidated Statements of Operations (Unaudited)
(In millions, except share and per share amounts)
 
Quarter ended December 31,
2011   2012
Patient service revenues $ 1,428.1   96.8 % $ 1,481.5   97.9 %
Less: Provision for doubtful accounts (141.5 ) (9.6 ) (161.7 ) (10.7 )
Patient service revenues, net 1,286.6 87.2 1,319.8 87.2
Premium revenues 188.8   12.8   193.3   12.8  
Total revenues 1,475.4 100.0 1,513.1 100.0
 
Salaries and benefits (includes stock compensation) 702.4 47.6 698.1 46.1
Health plan claims expense 147.3 10.0 149.8 9.9
Supplies 227.9 15.4 232.5 15.4
Purchased services 133.4 9.0 148.2 9.8
Rents and leases 18.7 1.3 18.8 1.2
Other operating expenses 131.3 8.9 145.1 9.6
Medicare and Medicaid EHR incentives (21.3 ) (1.4 ) (14.5 ) (1.0 )
Depreciation and amortization 65.8 4.5 67.8 4.5
Interest, net 43.2 2.9 49.7 3.3
Acquisition related expenses 0.4 0.1
Other (1.8 ) (0.1 ) (1.8 ) (0.1 )

Income from continuing operations before income taxes

28.1 1.9 19.3 1.3
Income tax expense (11.3 ) (0.8 ) (7.2 ) (0.5 )
Income from continuing operations 16.8 1.1 12.1 0.8
Loss from discontinued operations, net of taxes (0.3 )      
Net income 16.5 1.1 12.1 0.8
Net loss (income) attributable to non-controlling interests (0.8 ) (0.1 ) 0.1    

Net income attributable to Vanguard Health Systems, Inc. stockholders

$ 15.7   1.1 % $ 12.2   0.8 %
 
Earnings per share attributable to Vanguard Health Systems, Inc. stockholders
Basic earnings per share $ 0.21   $ 0.15  
Diluted earnings per share $ 0.20   $ 0.14  
 
Weighted average shares outstanding (in thousands):
Basic 75,325   77,421  
Diluted 78,732   79,625  
 
 
 
 
 
 
VANGUARD HEALTH SYSTEMS, INC.
Condensed Consolidated Statements of Operations (Unaudited)
(In millions, except share and per share amounts)
 
Six months ended December 31,
2011   2012
Patient service revenues $ 2,779.6   95.5 % $ 2,945.4   98.7 %
Less: Provision for doubtful accounts (267.7 ) (9.2 ) (331.3 ) (11.1 )
Patient service revenues, net 2,511.9 86.3 2,614.1 87.6
Premium revenues 399.8   13.7   369.7   12.4  
Total revenues 2,911.7 100.0 2,983.8 100.0
 
Salaries and benefits (includes stock compensation) 1,367.4 47.0 1,378.3 46.2
Health plan claims expense 312.0 10.7 284.1 9.5
Supplies 441.5 15.2 458.6 15.4
Purchased services 260.4 8.9 295.4 9.9
Rents and leases 36.7 1.3 37.8 1.3
Other operating expenses 264.4 9.1 289.3 9.7
Medicare and Medicaid EHR incentives (24.4 ) (0.8 ) (25.8 ) (0.9 )
Depreciation and amortization 128.4 4.4 133.4 4.5
Interest, net 89.0 3.1 100.5 3.4
Debt extinguishment costs 38.9 1.3
Acquisition related expenses 12.6 0.4 0.1
Other (4.2 ) (0.1 ) (6.9 ) (0.2 )

Income (loss) from continuing operations before income taxes

(11.0 ) (0.4 ) 39.0 1.3
Income tax benefit (expense) 3.9   0.1   (12.1 ) (0.4 )
Income (loss) from continuing operations (7.1 ) (0.2 ) 26.9 0.9
Income (loss) from discontinued operations, net of taxes (0.4 )   0.1    
Net income (loss) (7.5 ) (0.3 ) 27.0 0.9
Net loss (income) attributable to non-controlling interests 1.5   0.1   (0.9 )  

Net income (loss) attributable to Vanguard Health Systems, Inc. stockholders

$ (6.0 ) (0.2 )% $ 26.1   0.9 %
 
Earnings (loss) per share attributable to Vanguard Health Systems, Inc. stockholders
Basic earnings (loss) per share $ (0.08 ) $ 0.32  
Diluted earnings (loss) per share $ (0.08 ) $ 0.31  
 
Weighted average shares outstanding (in thousands):
Basic 75,090   76,559  
Diluted 75,090   79,205  
 
 
 
 
 
 
VANGUARD HEALTH SYSTEMS, INC.
Supplemental Financial Information (Unaudited)
Reconciliation of Adjusted EBITDA to Net Income (Loss)

Attributable to Vanguard Health Systems, Inc. Stockholders

(In millions)
       
Quarter endedSix months ended
December 31,December 31,
2011201220112012

Net income (loss) attributable to Vanguard Health Systems, Inc. stockholders

$ 15.7 $ 12.2 $ (6.0 ) $ 26.1
Interest, net 43.2 49.7 89.0 100.5
Income tax expense (benefit) 11.3 7.2 (3.9 ) 12.1
Depreciation and amortization 65.8 67.8 128.4 133.4
Non-controlling interests 0.8 (0.1 ) (1.5 ) 0.9
Loss (gain) on disposal of assets 0.4 1.9 (0.8 ) 1.0
Equity method loss (income) (0.6 ) 0.2 (0.7 ) (0.4 )
Stock compensation 3.9 2.7 4.6 4.9
Realized losses on investments 0.2
Acquisition related expenses 0.4 0.1 12.6 0.1
Debt extinguishment costs 38.9
Impairment and restructuring charges (0.1 )
Pension credits (1.6 ) (3.9 ) (2.6 ) (7.7 )
Discontinued operations, net of taxes 0.3     0.4   (0.1 )

Adjusted EBITDA(1)

$ 139.6   $ 137.8   $ 258.3   $ 271.0  

____________________

(1) Adjusted EBITDA is defined as income (loss) before interest expense (net of interest income), income taxes, depreciation and amortization, non-controlling interests, gain or loss on disposal of assets, equity method income or loss, stock compensation, realized gains or losses on investments, acquisition related expenses, debt extinguishment costs, impairment and restructuring charges, pension expense (credits) and discontinued operations, net of taxes. Adjusted EBITDA is not intended as a substitute for net income (loss) attributable to Vanguard Health Systems, Inc. stockholders, operating cash flows or other cash flow data determined in accordance with accounting principles generally accepted in the United States. Due to varying methods of calculation, Adjusted EBITDA as presented may not be comparable to similarly titled measures of other companies.

 
 
 
 
 
 
VANGUARD HEALTH SYSTEMS, INC.
Condensed Consolidated Balance Sheets (Unaudited)
(In millions)
   
June 30, 2012December 31, 2012
ASSETS
Current assets:
Cash and cash equivalents $ 455.5 $ 357.8
Restricted cash 2.4 5.7

Accounts receivable, net of allowance for doubtful accounts of $366.5 and $382.1, respectively

 

702.1 666.4
Inventories 97.0 96.6
Deferred tax assets 89.6 71.0
Prepaid expenses and other current assets 236.4   197.1  
Total current assets 1,583.0 1,394.6
Property, plant and equipment, net of accumulated depreciation 2,110.1 2,145.3
Goodwill 768.4 772.7
Intangible assets, net of accumulated amortization 89.0 87.8
Deferred tax assets, noncurrent 71.2 82.9
Investments in securities 51.8 57.9
Escrowed cash for capital commitments 20.3
Other assets 94.3   97.2  
Total assets $ 4,788.1   $ 4,638.4  
 
LIABILITIES AND EQUITY
Current liabilities:
Accounts payable $ 390.6 $ 369.1
Accrued salaries and benefits 226.0 220.5
Accrued health plan claims and settlements 67.8 63.0
Accrued interest 73.2 73.4
Other accrued expenses and current liabilities 219.9 162.8
Current maturities of long-term debt 11.2   12.6  
Total current liabilities 988.7 901.4
Professional and general liability and workers compensation reserves 304.8 305.7
Unfunded pension liability 269.9 229.9
Other liabilities 174.7 123.1
Long-term debt, less current maturities 2,695.4 2,690.6
Commitments and contingencies
Redeemable non-controlling interests 53.1 55.3
Equity:
Vanguard Health Systems, Inc. stockholders' equity:
Common stock 0.8 0.8
Additional paid-in capital 403.3 405.0
Accumulated other comprehensive loss (48.4 ) (46.5 )
Retained deficit (60.6 ) (34.5 )
Total Vanguard Health Systems, Inc. stockholders' equity 295.1 324.8
Non-controlling interests 6.4   7.6  
Total equity 301.5   332.4  
Total liabilities and equity $ 4,788.1   $ 4,638.4  
 
 
 
 
 
 
VANGUARD HEALTH SYSTEMS, INC.
Condensed Consolidated Statements of Cash Flows (Unaudited)
(In millions)
  Six months ended
December 31,
2011   2012
Operating activities:
Net income (loss) $ (7.5 ) $ 27.0
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Loss (income) from discontinued operations 0.4 (0.1 )
Depreciation and amortization 128.4 133.4
Amortization of loan costs and accretion of principal on notes 8.4 6.6
Acquisition related expenses 12.6 0.1
Stock compensation 4.6 4.9
Deferred income taxes (5.9 ) 7.0
Debt extinguishment costs 38.9
Other (1.1 ) 1.2
Changes in operating assets and liabilities, net of the impact of acquisitions (172.2 ) (92.9 )
Net cash provided by operating activities — continuing operations 6.6 87.2
Net cash provided by (used in) operating activities — discontinued operations (0.4 ) 0.1  
Net cash provided by operating activities 6.2 87.3
 
Investing activities:
Acquisitions and related expenses, net of cash acquired (208.8 ) (7.2 )
Capital expenditures (137.2 ) (187.2 )
Proceeds from sales of investments in securities 42.3 76.1
Purchases of investments in securities (30.4 ) (79.1 )
Net reimbursements from restricted cash and escrow fund 17.8
Other investing activities (0.7 ) 1.3  
Net cash used in investing activities (334.8 ) (178.3 )
 
Financing activities:
Payments of long-term debt and capital leases (460.7 ) (5.5 )
Proceeds from the issuance of common stock 67.5
Payments of IPO related costs (6.9 )
Payments of tender premiums on note redemptions (27.6 )
Other financing activities (1.6 ) (1.2 )
Net cash used in financing activities (429.3 ) (6.7 )
Net decrease in cash and cash equivalents (757.9 ) (97.7 )
Cash and cash equivalents, beginning of period 936.6   455.5  
Cash and cash equivalents, end of period $ 178.7   $ 357.8  
 
Supplemental cash flow information:
Net cash paid for interest $ 81.0   $ 93.8  
Net cash paid for income taxes $ 0.6   $ 4.4  
 
 
 
 
 
 
VANGUARD HEALTH SYSTEMS, INC.
Segment Information (Unaudited)
(In millions)
           
Quarter ended December 31, 2011
Acute Care% ofHealth% of
ServicesRevenuesPlansRevenuesEliminationsConsolidated

Patient service revenues, net(1)

$ 1,297.1 100.0 % $

%

 

$

(10.5 ) $ 1,286.6
Premium revenues     188.8   100.0     188.8  
Total revenues 1,297.1 100.0 188.8 100.0 (10.5 ) 1,475.4
 

Salaries and benefits (excludes stock compensation)

689.2 53.1 9.3 4.9 698.5

Health plan claims expense(1)

157.8 83.6 (10.5 ) 147.3
Supplies 227.9 17.6 227.9
Other operating expenses 271.2 20.9 12.2 6.5 283.4
Medicare and Medicaid

EHR incentives

(21.3 ) (1.6 )       (21.3 )

Segment EBITDA(2)

130.1 10.0 9.5 5.0 139.6
Less:
Interest, net 43.8 3.4 (0.6 ) (0.3 ) 43.2
Depreciation and amortization 64.6 5.0 1.2 0.6 65.8
Equity method income (0.6 ) (0.6 )
Stock compensation 3.9 0.3 3.9
Loss on disposal of assets 0.4 0.4
Acquisition related expenses 0.4 0.4
Pension credits (1.6 ) (0.1 )       (1.6 )

Income from continuing operations before income taxes

$ 19.2   1.5 % $ 8.9   4.7 % $   $ 28.1  

___________________

(1) We eliminate in consolidation those patient service revenues earned by our health care facilities attributable to services provided to enrollees in our owned health plans and eliminate the corresponding medical claims expenses incurred by our health plans for those services.

 

(2) Segment EBITDA is defined as income (loss) from continuing operations before income taxes less interest expense (net of interest income), depreciation and amortization, equity method income or loss, stock compensation, gain or loss on disposal of assets, realized gains or losses on investments, acquisition related expenses, debt extinguishment costs, impairment and restructuring charges and pension expense (credits). Management uses Segment EBITDA to measure the performance of our segments and develop strategic objectives and operating plans for those segments. Segment EBITDA eliminates the uneven effect of non-cash depreciation of tangible assets and amortization of intangible assets, much of which results from acquisitions accounted for under the purchase method of accounting. Segment EBITDA also eliminates the effects of changes in interest rates, which management believes relate to general trends in global capital markets, but are not necessarily indicative of the operating performance of our segments. Management believes that Segment EBITDA provides useful information to investors, lenders, financial analysts and rating agencies about the financial performance of our segments. Additionally, management believes that investors and lenders view Segment EBITDA as an important factor in making investment decisions concerning us. Segment EBITDA is not a substitute for net income (loss), operating cash flows or other cash flow statement data determined in accordance with accounting principles generally accepted in the United States. Segment EBITDA, as presented, may not be comparable to similar measures of other companies.

 
 
 
 
 
 
VANGUARD HEALTH SYSTEMS, INC.
Segment Information (Unaudited) (continued)
(In millions)
           
Quarter ended December 31, 2012
Acute Care% ofHealth% of
ServicesRevenuesPlansRevenuesEliminationsConsolidated

Patient service revenues, net(1)

$ 1,329.3 100.0 % $

%

$ (9.5 ) $ 1,319.8
Premium revenues     193.3   100.0     193.3  
Total revenues 1,329.3 100.0 193.3 100.0 (9.5 ) 1,513.1
 

Salaries and benefits (excludes stock compensation)

685.3 51.6 10.1 5.2 695.4

Health plan claims expense(1)

159.3 82.4 (9.5 ) 149.8
Supplies 232.4 17.5 0.1 0.1 232.5
Other operating expenses 301.1 22.7 11.0 5.7 312.1
Medicare and Medicaid

EHR incentives

(14.5 ) (1.1 )       (14.5 )

Segment EBITDA(2)

125.0 9.4 12.8 6.6 137.8
Less:
Interest, net 50.3 3.8 (0.6 ) (0.3 ) 49.7
Depreciation and amortization 66.7 5.0 1.1 0.6 67.8
Equity method loss 0.2 0.2
Stock compensation 2.7 0.2 2.7
Loss on disposal of assets 1.9 0.1 1.9
Acquisition related expenses 0.1 0.1
Pension credits (3.9 ) (0.3 )       (3.9 )

Income from continuing operations before income taxes

$ 7.0   0.5 % $ 12.3   6.5 % $   $ 19.3  

__________________

(1) We eliminate in consolidation those patient service revenues earned by our health care facilities attributable to services provided to enrollees in our owned health plans and eliminate the corresponding medical claims expenses incurred by our health plans for those services.

 

(2) Segment EBITDA is defined as income (loss) from continuing operations before income taxes less interest expense (net of interest income), depreciation and amortization, equity method income or loss, stock compensation, gain or loss on disposal of assets, realized gains or losses on investments, acquisition related expenses, debt extinguishment costs, impairment and restructuring charges and pension expense (credits). Management uses Segment EBITDA to measure the performance of our segments and develop strategic objectives and operating plans for those segments. Segment EBITDA eliminates the uneven effect of non-cash depreciation of tangible assets and amortization of intangible assets, much of which results from acquisitions accounted for under the purchase method of accounting. Segment EBITDA also eliminates the effects of changes in interest rates, which management believes relate to general trends in global capital markets, but are not necessarily indicative of the operating performance of our segments. Management believes that Segment EBITDA provides useful information to investors, lenders, financial analysts and rating agencies about the financial performance of our segments. Additionally, management believes that investors and lenders view Segment EBITDA as an important factor in making investment decisions concerning us. Segment EBITDA is not a substitute for net income (loss), operating cash flows or other cash flow statement data determined in accordance with accounting principles generally accepted in the United States. Segment EBITDA, as presented, may not be comparable to similar measures of other companies.

 
 
 
 
 
 
VANGUARD HEALTH SYSTEMS, INC.
Segment Information (Unaudited) (continued)
(In millions)
           
Six months ended December 31, 2011
Acute Care% ofHealth% of
ServicesRevenuesPlansRevenuesEliminationsConsolidated

Patient service revenues, net(1)

$ 2,531.0 100.0 % $

%

$ (19.1 ) $ 2,511.9
Premium revenues     399.8   100.0     399.8  
Total revenues 2,531.0 100.0 399.8 100.0 (19.1 ) 2,911.7
 

Salaries and benefits (excludes stock compensation)

1,344.5 53.1 18.3 4.6 1,362.8

Health plan claims expense(1)

331.1 82.8 (19.1 ) 312.0
Supplies 441.4 17.4 0.1 441.5
Other operating expenses 538.6 21.3 22.9 5.7 561.5
Medicare and Medicaid

EHR incentives

(24.4 ) (1.0 )       (24.4 )

Segment EBITDA(2)

230.9 9.1 27.4 6.9 258.3
Less:
Interest, net 89.9 3.6 (0.9 ) (0.2 ) 89.0
Depreciation and amortization 126.1 5.0 2.3 0.6 128.4
Equity method income (0.7 ) (0.7 )
Stock compensation 4.6 0.2 4.6
Gain on disposal of assets (0.8 ) (0.8 )
Acquisition related expenses 12.6 0.5 12.6
Debt extinguishment costs 38.9 1.5 38.9
Impairment and restructuring charges (0.1 ) (0.1 )
Pension credits (2.6 ) (0.1 )       (2.6 )

Income (loss) from continuing operations before income taxes

$ (37.0 ) (1.5 )% $ 26.0   6.5 % $   $ (11.0 )

__________________

(1) We eliminate in consolidation those patient service revenues earned by our health care facilities attributable to services provided to enrollees in our owned health plans and eliminate the corresponding medical claims expenses incurred by our health plans for those services.

 

(2) Segment EBITDA is defined as income (loss) from continuing operations before income taxes less interest expense (net of interest income), depreciation and amortization, equity method income or loss, stock compensation, gain or loss on disposal of assets, realized gains or losses on investments, acquisition related expenses, debt extinguishment costs, impairment and restructuring charges and pension expense (credits). Management uses Segment EBITDA to measure the performance of our segments and develop strategic objectives and operating plans for those segments. Segment EBITDA eliminates the uneven effect of non-cash depreciation of tangible assets and amortization of intangible assets, much of which results from acquisitions accounted for under the purchase method of accounting. Segment EBITDA also eliminates the effects of changes in interest rates, which management believes relate to general trends in global capital markets, but are not necessarily indicative of the operating performance of our segments. Management believes that Segment EBITDA provides useful information to investors, lenders, financial analysts and rating agencies about the financial performance of our segments. Additionally, management believes that investors and lenders view Segment EBITDA as an important factor in making investment decisions concerning us. Segment EBITDA is not a substitute for net income (loss), operating cash flows or other cash flow statement data determined in accordance with accounting principles generally accepted in the United States. Segment EBITDA, as presented, may not be comparable to similar measures of other companies.

 
 
 
 
 
 
VANGUARD HEALTH SYSTEMS, INC.
Segment Information (Unaudited) (continued)
(In millions)
           
Six months ended December 31, 2012
Acute Care% ofHealth% of
ServicesRevenuesPlansRevenuesEliminationsConsolidated

Patient service revenues, net(1)

$ 2,633.8 100.0 % $

%

$ (19.7 ) $ 2,614.1
Premium revenues     369.7   100.0     369.7  
Total revenues 2,633.8 100.0 369.7 100.0 (19.7 ) 2,983.8
 

Salaries and benefits (excludes stock compensation)

1,354.4 51.4 19.0 5.1 1,373.4

Health plan claims expense(1)

303.8 82.2 (19.7 ) 284.1
Supplies 458.5 17.4 0.1 458.6
Other operating expenses 600.3 22.8 22.2 6.0 622.5
Medicare and Medicaid

EHR incentives

(25.8 ) (1.0 )       (25.8 )

Segment EBITDA(2)

246.4 9.4 24.6 6.7 271.0
Less:
Interest, net 101.6 3.9 (1.1 ) (0.3 ) 100.5
Depreciation and amortization 131.3 5.0 2.1 0.6 133.4
Equity method income (0.4 ) (0.4 )
Stock compensation 4.9 0.2 4.9
Loss on disposal of assets 1.0 1.0
Realized losses on investments 0.2 0.2
Acquisition related expenses 0.1 0.1
Pension credits (7.7 ) (0.3 )       (7.7 )

Income from continuing operations before income taxes

$ 15.4   0.6 % $ 23.6   6.5 % $   $ 39.0  

__________________

(1) We eliminate in consolidation those patient service revenues earned by our health care facilities attributable to services provided to enrollees in our owned health plans and eliminate the corresponding medical claims expenses incurred by our health plans for those services.

 

(2) Segment EBITDA is defined as income (loss) from continuing operations before income taxes less interest expense (net of interest income), depreciation and amortization, equity method income or loss, stock compensation, gain or loss on disposal of assets, realized gains or losses on investments, acquisition related expenses, debt extinguishment costs, impairment and restructuring charges and pension expense (credits). Management uses Segment EBITDA to measure the performance of our segments and develop strategic objectives and operating plans for those segments. Segment EBITDA eliminates the uneven effect of non-cash depreciation of tangible assets and amortization of intangible assets, much of which results from acquisitions accounted for under the purchase method of accounting. Segment EBITDA also eliminates the effects of changes in interest rates, which management believes relate to general trends in global capital markets, but are not necessarily indicative of the operating performance of our segments. Management believes that Segment EBITDA provides useful information to investors, lenders, financial analysts and rating agencies about the financial performance of our segments. Additionally, management believes that investors and lenders view Segment EBITDA as an important factor in making investment decisions concerning us. Segment EBITDA is not a substitute for net income (loss), operating cash flows or other cash flow statement data determined in accordance with accounting principles generally accepted in the United States. Segment EBITDA, as presented, may not be comparable to similar measures of other companies.

 
 
 
 
 
 
VANGUARD HEALTH SYSTEMS, INC.
Selected Operating Statistics
(Unaudited)
 
  Quarter ended  

CONSOLIDATED AND SAME STORE:

December 31,
2011   2012% Change
Number of hospitals at end of period 28 28
Licensed beds at end of period 7,064 7,064
Discharges 71,961 70,980 (1.4 )%
Adjusted discharges 129,089 130,924 1.4
Average length of stay 4.39 4.47 1.8
Patient days 316,075 317,369 0.4
Adjusted patient days 566,997 585,394 3.2
Patient revenue per adjusted discharge $ 9,506 $ 9,647 1.5
Inpatient surgeries 16,910 16,345 (3.3 )
Outpatient surgeries 31,876 31,444 (1.4 )
Observation cases 17,750 19,170 8.0
Emergency room visits 299,075 317,069 6.0
Health plan member lives 249,500 236,000 (5.4 )
Health plan claims expense percentage 78.0 % 77.5 %
 

Uncompensated care as a percent of net patient revenues (prior to uncompensated care deductions)

20.0 % 21.3 %
 
Net patient revenue payer mix:
Medicare 28.2 % 27.1 %
Medicaid 13.9 13.4
Managed Medicare 11.1 11.7
Managed Medicaid 8.7 10.2
Managed care 34.5 34.1
Commercial

1.2

1.5
Self-pay

2.4

  2.0  
Total 100.0 % 100.0 %
 
Discharges by payer:
Medicare 29.5 % 29.1 %
Medicaid 11.8 9.8
Managed Medicare 12.1 12.7
Managed Medicaid 16.4 18.2
Managed care 22.8 22.3
Commercial 0.5 0.5
Self-pay 6.9   7.4  
Total 100.0 % 100.0 %
 
 
 
 
 
 
VANGUARD HEALTH SYSTEMS, INC.
Selected Operating Statistics
(Unaudited) (continued)
 
  Six months ended  

CONSOLIDATED:

December 31,
2011   2012% Change
Number of hospitals at end of period 28 28
Licensed beds at end of period 7,064 7,064
Discharges 140,122 142,461 1.7 %
Adjusted discharges 254,345 262,430 3.2
Average length of stay 4.37 4.44 1.6
Patient days 612,154 632,924 3.4
Adjusted patient days 1,111,161 1,165,919 4.9
Patient revenue per adjusted discharge $ 9,397 $ 9,525 1.4
Inpatient surgeries 32,987 32,937 (0.2 )
Outpatient surgeries 61,852 62,575 1.2
Observation cases 34,107 38,398 12.6
Emergency room visits 591,914 632,104 6.8
Health plan member lives 249,500 236,000 (5.4 )
Health plan claims expense percentage 78.0 % 76.8 %
 

Uncompensated care as a percent of net patient revenues (prior to uncompensated care deductions)

19.0 % 21.5 %
 
Net patient revenue payer mix:
Medicare 27.4 % 27.3 %
Medicaid 14.3 13.5
Managed Medicare 10.7 11.5
Managed Medicaid 9.6 10.1
Managed care 34.8 34.1
Commercial

1.3

1.5
Self-pay

1.9

  2.0  
Total 100.0 % 100.0 %
 
Discharges by payer:
Medicare 28.9 % 28.5 %
Medicaid 11.2 9.7
Managed Medicare 12.2 12.5
Managed Medicaid 17.1 18.4
Managed care 23.0 22.5
Commercial 0.5 0.5
Self-pay 7.1   7.9  
Total 100.0 % 100.0 %
 
 
 
 
 
 
VANGUARD HEALTH SYSTEMS, INC.
Selected Operating Statistics
(Unaudited) (continued)
 
  Six months ended  

SAME STORE:

December 31,
2011   2012% Change
Number of hospitals at end of period 26 26
Licensed beds at end of period 6,198 6,198
Total revenues, including premium revenues (in millions) $ 2,771.4 $ 2,769.0 (0.1 )%
Net patient service revenues (in millions) $ 2,382.7 $ 2,420.8 1.6
Discharges 130,868 128,520 (1.8 )
Adjusted discharges 241,323 240,792 (0.2 )
Average length of stay 4.34 4.42 1.8
Patient days 567,700 567,483
Adjusted patient days 1,046,849 1,063,223 1.6
Patient revenue per adjusted discharge $ 9,383 $ 9,598 2.3
Inpatient surgeries 30,205 28,921 (4.3 )
Outpatient surgeries 58,605 57,401 (2.1 )
Observation cases 31,799 34,683 9.1
Emergency room visits 565,499 586,747 3.8
Health plan claims expense percentage 78.2 % 76.8 %
 

Uncompensated care as a percent of net patient revenues (prior to uncompensated care deductions)

18.0 % 20.2 %
 
Net patient revenue payer mix:
Medicare 26.7 % 26.3 %
Medicaid 14.1 13.4
Managed Medicare 10.9 11.7
Managed Medicaid 10.3 10.5
Managed care 35.0 34.7
Commercial 1.4 1.5
Self-pay 1.6   1.9  
Total 100.0 % 100.0 %
 
Discharges by payer:
Medicare 28.6 % 28.3 %
Medicaid 10.0 9.3
Managed Medicare 12.7 13.1
Managed Medicaid 18.2 18.0
Managed care 23.3 23.0
Commercial 0.5 0.6
Self-pay 6.7   7.7  
Total 100.0 % 100.0 %
 
 

Contacts:

Vanguard Health Systems, Inc.
Investor Contact:
Gary Willis, 615-665-6098
Senior Vice President and Chief Accounting Officer
gwillis@vanguardhealth.com
or
Media Contact:
Suzanne Towry, 615-665-6016
Director of Media Relations
setowry@vanguardhealth.com

Source: Vanguard Health Systems, Inc.

© 2014 Canjex Publishing Ltd. All rights reserved.